Refine your search
Collections
Co-Authors
Journals
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Lakshmi Prasanna, J.
- Malabsorption of Drugs in Gastrointestinal Diseases: a Review
Abstract Views :2795 |
PDF Views:0
Authors
Affiliations
1 Department of pharmaceutics, Chalapathi Institute of Pharmaceutical Sciences, Lam, Guntur- 522034, IN
1 Department of pharmaceutics, Chalapathi Institute of Pharmaceutical Sciences, Lam, Guntur- 522034, IN
Source
Research Journal of Pharmacy and Technology, Vol 6, No 1 (2013), Pagination: 29-33Abstract
Most long term treatments follow the oral administration due to its ease and convenience of administration. After oral administration of any drug, the plasma concentration time curve is a function of many simultaneously operating kinetic processes. The steady state plasma concentration is achieved when the amount of drug absorbed equals the amount of drug eliminated. Both amount and rate of drug absorbed may be altered by diseases which in turn alter other kinetic processes. The amount of drug absorbed is simultaneously affected by physicochemical factors of drug and physiological factors that operate in gut which are also altered by the disease state. The present review focuses on the way in which the absorption of drugs is altered in various conditions of gastro intestinal tract.Keywords
Gastric Emptying Rate, Malabsorption, Peak Plasma Concentration, MetaclopramideReferences
- Peter welling G, Francis Tse LS and Shrikant Dighe V. Pharmaceutical bioequivalence. Marcel Dekker.Inc., New York. 2006; pp. 67-88.
- Venkateswarlu V. Biopharmaceutics and pharmacokinetics. Pharmamed press, Hyderabad. pp.58.
- Roert Notari E. Biopharmaceutics and pharmacokinetics an introduction. Marcel Dekker.Inc., New York. 2005; pp. 141-142.
- Parsons RL. Drug absorption in gastro intestinal disease with particular reference to malabsorption syndromes. Clinical pharmacokinetics. 2(1); 1977: 45-60.
- Chisholm GD, Watertworth PM, Calnan JS and Garrod LP. Concentration of antimicrobial agents in intestinal tissue fluid. British medical journal. 1; 1973: 569-573.
- Parsons RL and Paddock GM. Aborption of two antimicrobial drugs, cephalexin and co-trimazole in malabsorption syndromes. Journal of antimicrobial therapy. 1 (1); 1975: 59-67.
- Harsha mohan. The gastro intestinal tract in textbook of pathology. Jaypee brothers medical publishers (p) ltd., New Delhi. 2010; 6th ed: pp.538-591.
- Ross and Wilson. Anatomy and Physiology in health and illness. Churchill Living Stone, New York. 2007; 10th ed: pp.281 – 335.
- Madan PL. Biopharmaceutics and pharmacokinetics. Jaypee brother’s medical publishers (p) ltd., New Delhi. 2000; pp.112.
- Jussila J, Matilla MJ and Takki S. Drug absorption during lactose induced intestinal symptoms in patients with selective lactose malabsorption. Annals medicine experimentalist. Biologiae fenniae. 48; 1970: 33-37.
- Nelson JD, Shelton S Kusmiesz HT and Haltalin K. Absorption of ampicillin and nalidixic acid by infants and children with acute shigellosis. Clinical pharmacology and therapeutics. 13; 1972: 879-886.
- Haiverson L, Doterall G and Wallan A. gastric Emptying in patients with achlorhydria or hyposecretion of hydrochloric acid. Scandinavian journal of gastroenterology. 8; 1973: 395-399.
- Parsons RL, Hossack GA and Paddock GM. The absorption of antibiotics in adult patients with celiac disease. Journal of antimicrobial chemotherapy. 1; 1975: 39-50.
- Parsons RL, Jusko WJ and Lewis GP. Pharmacokinetics of antibiotic absorption in coeliac disease. Journal of antimicrobial chemotherapy. 2(2); 1976: 214-215.
- Parsons Rl, Kaye CM, Raymond K, Trounce TR and Turner P. Absorptio of propanolol and practolol in celiac disease. Gut. 17(2); 1976: 139-143.
- Parsons RL, Hossack GA, Paddock GM and Hailey Dm. In Williams and Geddes, editors. Antibiotic absorption inchrons disease: Chemotherapy Pharmacology of antibiotics. Plenum press, New York. 1976; Vol 4: pp.219-229.
- Anthonisen P, Barany F, Folken borg O, Holtz A, Jarnum S, Kristenson M, Riss P, Walan A and Worning H. The clinical effect of salazosulpapyridine (salazopyrin) in crohn’s disease A controlled blind study. Scandinavian journal of gastroenterology. 9; 1974: 549-554.
- Goldman P, Peppercorn MA and Goldin BR. In Morselli, cohen and Garatti editors. Drugs metabolized by intestinal microflora: Drug interactions. Raven Press, New York. 1974; pp.91.
- Bushby SRM and Hitchings GH. Trimethoprim, a sulphonamide potentiator. British journal of pharmacology and chemotherapy. 33, 1968: 72-90.
- Roert Notari E. Biopharmaceutics and pharmacokinetics an introduction. Marcel dekker.Inc. New York. 2005; pp. 160-162.
- A Review on Packaging for Different Formulations
Abstract Views :742 |
PDF Views:2
Authors
Affiliations
1 Chalapathi Institute of Pharmaceutical Sciences, Lam, Guntur, A.P., IN
1 Chalapathi Institute of Pharmaceutical Sciences, Lam, Guntur, A.P., IN
Source
Asian Journal of Research in Pharmaceutical Sciences, Vol 4, No 3 (2014), Pagination: 141-151Abstract
Encase of all pharmaceutical products, with a clear information i.e;label about the information of drug nature, quantity manufacturing date and expiry date, with a clear information on storage of drugs. Single label shows whole information about drug. Packaging gives more information for a layman people about the use of drug.Nowdays packaging development is more important along with the drugsafety.packaging should be firm and safe up to the enduser of product. Packaging means a blends of science and technology. Packaging area not only helps in creation of wealth, preserving product quality, but also lengthens the shelf life of products. Growing demand of packaging in the pharmaceutical companies there is a demand for packaging professionals for producing consistent qualitative packaging materials in optimum cost. This review provides a brief introduction about packaging functions and packaging materials for different formulations like solid dosage forms, semisolid dosage forms, oral liquids, parenteral, liposome and transdermal patches.Keywords
Packaging, Tamper Resistant Packaging, Liposome's, Suppositories, Packaging Materials.References
- Jain UK, Nayak S. 1st ed. Hyderabad: Pharma Med Press; 2008. Pharmaceutical Packaging Technology; pp. 1-273.
- Carter SJ. Copper and Gunn's Packaging in Tutorial Pharmacy. 2005:133-41.
- M.E. Aulton. "The Science of Dosage Form Design", Secondedition.pageno:554-570
- World Health Organization, 2002. Guidelines on packaging for pharmaceutical Product, Annex 9, 2002.tests on biodegradable plastic materials. (WHO Technical Report Series, No. 902).
- (WHO Technical Report Series, No. 902) http://www.who.int/medicines/areas/quality assurance/regulatory standards/en/index html
- World Health Organization. Annex 9, Guidelines on packaging for pharmaceutical products, WHO Technical Report Series, No. 902, 2002.
- Good manufacturing practices for pharmaceutical products. In: WHO Expert Committee on Specifications for Pharmaceutical Preparations. Thirty-second report. Geneva, World Health Organization, 1992, Annex 1 (WHO Technical Report Series, No. 823).
- Trends in pharmaceutical packaging. [Last accessed on 2001 Oct 19]. Available from:http://www.ngpharma.eu.com/article/Trendsin-pharmaceutical-packaging
- Matthew S. Thomas Associate Senior Consultant Engineer, Pharmaceutical Packaging Development, Eli Lilly and Company October 2nd, 2010
- Manoi, Shekhawati College of pharmacy, Dundlod. Pharmatutor. Review on: the pharmaceutical packaging
- Availableonline http://www.ipharmsciencia.com. Internationale Pharmaceutica Sciencia 2012; 2:2.
- Michael J. Akers, PhD. http://www.pharmpress.com/files/docs/Remington_Ch_26.pdf, Sample chapter from Remington: Essentials of Pharmaceutics, Parenteral Preparations pg no 495-532
- Packaging/Container Issues: Unit-dose, Pre-filled Syringes, Prepacks, Etc. International journal of pharmaceutical compounding.2011;1: 6
- Mehta Kunal C, Akhilesh.D and Shyam Kumar.B, Recent Trends in Pharmaceutical Packaging: A review. International journal of pharmaceutical and chemical sciences .2012; 1:3. pg no: 932-944
- Devi KV, Burande M, Deepak H, Jobanputra SB. Packaging solutions to the changing pharma market needs. Pharma Times. 2007; 39:29-34.
- .http://www.meridianentp.com/productsub/meridian_newsuppository.php.suppository packaging
- http://avantilipids.com/index.php?view=itemsandcid= 5andid=13andoption=com_quickfaqandItemid=385.Packaging for liposome's
- Solid Dispersions-An Approach to Enhance the Dissolution Rate of Clopidogrel Bisulphate
Abstract Views :303 |
PDF Views:0
Authors
Affiliations
1 Chalapathi Institute of Pharmaceutical Sciences, Lam, Guntur, A.P, IN
1 Chalapathi Institute of Pharmaceutical Sciences, Lam, Guntur, A.P, IN
Source
Asian Journal of Research in Pharmaceutical Sciences, Vol 4, No 4 (2014), Pagination: 165-168Abstract
Solid dispersions are one of the techniques to improve the solubility of the poorly soluble drugs. In this technique a poorly soluble drug is dispersed in the highly soluble hydrophilic matrix, two types of polymers are considered as carriers i.e., lactose, dextrose and cornstarch. Solubility is the basic step for formulation of different type of dosage forms. clopidogrel bisulphate is a BCS class II drug having low solubility and high permeability, used as ant platelet drug to inhibit blood clots in coronary artery disease, peripheral vascular disease and cerebrovascular disease. In this research article Clopidogrel bisulphate solubility has been increased by co-grinding method i.e.,one of the solid dispersion technique lactose (1:5,1:10,1:15), dextrose (1:10,1:15) cornstarch:lactose (1:10,1:15) from three different polymers cornstarch: lactose showed 99%solubility than dextrose and lactose. In-vitro dissolution studies were conducted in PH 6.8 buffer.Keywords
Clopidogrel Bisulphate, Solid Dispersions, Antiplatelet, Cornstarch, Lactose.- Rectal Drug Delivery:A Promising Route for Enhancing Drug Absorption
Abstract Views :373 |
PDF Views:1
Authors
Affiliations
1 Department of Pharmaceutics, Chalapathi Institute of Pharmaceutical Sciences, Lam, Guntur- 522034, IN
1 Department of Pharmaceutics, Chalapathi Institute of Pharmaceutical Sciences, Lam, Guntur- 522034, IN
Source
Asian Journal of Research in Pharmaceutical Sciences, Vol 2, No 4 (2012), Pagination: 143-149Abstract
Rectal drug delivery is an efficient alternate to oral and parenteral route of administration in partial avoidance of first pass metabolism and protein peptide drug delivery. This route allows both local and systemic therapy of drugs. Controlled absorption enhancement of drugs can be achieved by the rectal route because of the constant conditions in the rectal environment. In the present review various absorption enhancers with their mechanism of action in improving drug absorption through rectal epithelium and the potential of rectal route in delivering protein and peptides, analgesics and antiepileptics are discussed. This review also presents affects of various absorption promoting adjuvant on the rectal absorption of drugs.Keywords
Rectal Absorption, Enamine Derivatives, Salicylates, Fatty Acids, Cyclodextrins, Protease Inhibitors.- TSP Based Matrix Tablets:Studying the Effect of Formulation Variables Employing Response Surface Methodology
Abstract Views :293 |
PDF Views:1
Authors
Affiliations
1 Department of Pharmaceutics, Chalapathi Institute of Pharmaceutical Sciences, Lam, Guntur-522034, IN
1 Department of Pharmaceutics, Chalapathi Institute of Pharmaceutical Sciences, Lam, Guntur-522034, IN